San Francisco, United States
MyMagic AI, founded in 2023, offers an innovative solution in the AI industry with its flagship product, an AI-driven Pharmacovigilance Co-Pilot. Their slogan, "AI Pharmacovigilance co-pilot to save 95% of your time and money," underscores its mission to transform the pharmacovigilance landscape by leveraging advanced artificial intelligence technologies.
This United States-based startup significantly enhances the efficiency and accuracy of monitoring, retrieving, and assessing scientific literature across various languages. By automating these processes, MyMagic AI reduces time and costs associated with traditional methods, allowing professionals to prioritize crucial decision-making while boosting patient safety and regulatory compliance.
The company's potential was recently recognized in a $200.00K seed investment round in September 2023, led by Berkeley SkyDeck. As they continue to innovate, MyMagic AI presents a compelling opportunity for investors interested in the intersection of AI and healthcare.
